Towards a molecular risk map--recent advances on the etiology of inflammatory bowel disease.

Authors:
Philip Rosenstiel, Christian Sina, Andre Franke, Stefan Schreiber
Year of publication:
2009
Volume:
21
Issue:
6
Issn:
1044-5323
Journal title abbreviated:
SEMIN IMMUNOL
Journal title long:
Seminars in immunology
Impact factor:
8.461
Abstract: 
Recent advances have enabled a comprehensive understanding of the genetic architecture of inflammatory bowel disease (IBD) with over 30 identified and replicated disease loci. The pathophysiological consequences of disease gene variants in Crohn disease and ulcerative colitis, the two main subentities of IBD, so far are only understood on the single disease gene level, yet complex network analyses linking the individual risk factors into a molecular risk map are still missing. In this review, we will focus on recent pathways and cellular functions that emerged from the genetic studies (e.g. innate immunity, autophagy) and delineate the existence of shared (e.g. IL23R, IL12B) and unique (e.g. NOD2 for CD) risk factors for the disease subtypes. Ultimately, the defined molecular profiles may identify individuals at risk early in life and may serve as a guidance to administer personalized interventions for causative therapies and/or early targeted prevention strategies. Due to this comparatively advanced level of molecular understanding in the field, IBD may represent precedent also for future developments of individualized genetic medicine in other polygenic disorders in general.